Risk Factors For Hepatotoxicity Of Nintedanib In Japanese Patients With Idiopathic Pulmonary Fibrosis

被引：0
|
作者：
Ikeda, S. [1 ]
Sekine, A. [1 ]
Baba, T. [1 ]
Yamakawa, H. [1 ]
Oda, T. [1 ]
Okuda, R. [1 ]
Kitamura, H. [1 ]
Ogura, T. [1 ]
机构：
[1] Kanagawa Cardiovasc & Resp Ctr, Yokohama, Kanagawa, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5396
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis
    Kato, Motoyasu
    Nakamura, Takahiro
    Kono, Kana
    Haraguchi, Mizuki
    Yamada, Tomoko
    Ihara, Hiroaki
    Takahashi, Fumiyuki
    Takahashi, Kazuhisa
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [32] Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage
    Ryerson, Christopher J.
    Kolb, Martin
    Richeldi, Luca
    Lee, Joyce
    Wachtlin, Daniel
    Stowasser, Susanne
    Poletti, Venerino
    [J]. ERJ OPEN RESEARCH, 2019, 5 (02)
  • [33] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Richeldi, Luca
    Kolb, Martin
    Jouneau, Stephane
    Wuyts, Wim A.
    Schinzel, Birgit
    Stowasser, Susanne
    Quaresma, Manuel
    Raghu, Ganesh
    [J]. BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [34] Outcomes in Patients Receiving Nintedanib or Pirfenidone for Idiopathic Pulmonary Fibrosis
    Cottin, V.
    Spagnolo, P.
    Bonniaud, P.
    Nolin, M.
    Dalon, F.
    Kirchgassler, K.
    Chia, J.
    Kamath, T. V.
    Van Ganse, E.
    Belhassen, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [35] COMBINATION THERAPY WITH NINTEDANIB AND PREDNISOLONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Kato, Motoyasu
    Nakamura, Takahiro
    Kurokawa, Kana
    Yamada, Tomoko
    Ihara, Hiroaki
    Takahashi, Fumiyuki
    Sasaki, Shinichi
    Takahashi, Kazuhisa
    [J]. RESPIROLOGY, 2018, 23 : 86 - 86
  • [36] Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in the USA
    Noth, Imre
    Oelberg, David
    Kaul, Manika
    Conoscenti, Craig S.
    Raghu, Ganesh
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (01)
  • [37] Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
    Kolb, Martin
    Richeldi, Luca
    Behr, Juergen
    Maher, Toby M.
    Tang, Wenbo
    Stowasser, Susanne
    Hallmann, Christoph
    du Bois, Roland M.
    [J]. THORAX, 2017, 72 (04) : 340 - 346
  • [38] Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis (vol 9, 12062, 2019)
    Kato, Motoyasu
    Sasaki, Shinichi
    Nakamura, Takahiro
    Kurokawa, Kana
    Yamada, Tomoko
    Ochi, Yusuke
    Ihara, Hiroaki
    Takahashi, Fumiyuki
    Takahashi, Kazuhisa
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] PROGNOSTIC FACTORS AND CAUSE OF DEATH IN JAPANESE PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Chiba, Hirofumi
    Natsuizaka, Motoki
    Otsuka, Mitsuo
    Kuronuma, Koji
    Sugiyama, Yukihiko
    Takahashi, Hiroki
    [J]. RESPIROLOGY, 2013, 18 : 198 - 198
  • [40] Risk factors for idiopathic pulmonary fibrosis
    Bouros, Demosthenes
    [J]. PNEUMON, 2013, 26 (02) : 117 - 119
12345